Sakurai S, Jojima T, Iijima T, Tomaru T, et al. Empagliflozin decreases the plasma concentration of plasminogen activator
inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with
improvement of fibrinolysis. J Diabetes Complications 2020 Jul 31:107703.
PMID: 32883567